BioInvent International AB: Interim Report January-March 2023

LUND, SE / ACCESSWIRE / April 26, 2023 / BioInvent International (STO:BINV)"After the end of the quarter, we received very positive news in our BI-1206 project. We now have a fourth complete response in the ongoing Phase 1/2 trial with BI-1206 in …